TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
VSee Health ( (VSEE) ) has issued an update.
On November 13, 2025, VSee Health, Inc. entered into an Exchange Agreement and a Directed Stock Purchase Agreement (DSPA) with an investor. The company plans to issue shares of its Common Stock under exemptions from the registration requirements of the Securities Act, specifically under Section 3(a)(9) and/or Regulation D for the Exchange Agreement, and Section 4(a)(2) and/or Regulation D for the DSPA. This move involves accredited investors as defined under Regulation D, potentially impacting VSee Health’s financial strategy and investor relations.
The most recent analyst rating on (VSEE) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Neutral.
VSee Health’s overall stock score is primarily impacted by its weak financial performance, characterized by negative profit margins and a precarious balance sheet. Technical analysis provides some hope for stabilization, but the bearish trend remains a concern. The valuation is unattractive due to the negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
Average Trading Volume: 12,966,155
Technical Sentiment Signal: Sell
Current Market Cap: $12.63M
For a thorough assessment of VSEE stock, go to TipRanks’ Stock Analysis page.